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SUMMARY		Of	their	diverse	roles	as	transcriptional	regulators	during	development	and	cell	fate	specification,	the	RUNX	transcription	factors	are	best	known	for	their	parts	in	 hematopoiesis.	 RUNX	 proteins	 are	 expressed	 throughout	 all	 hematopoietic	lineages,	being	requisite	for	the	emergence	of	the	first	hematopoietic	stem	cells	to	their	terminal	differentiation.	While	much	progress	has	been	made	since	their	discoveries	 almost	 two	 decades	 ago,	 current	 appreciation	 of	 RUNX	 in	hematopoiesis	is	 largely	grounded	on	their	lineage	specifying	roles.	In	contrast,	the	 importance	 of	 RUNX	 to	 immunity	 has	 been	 mostly	 obscured	 for	 historic,	technical	and	conceptual	reasons.	However,	this	paradigm	is	 likely	to	shift	over	time,	 since	 a	 primary	 purpose	 of	 hematopoiesis	 is	 to	 resource	 the	 immune	system.	 Furthermore,	 recent	 evidence	 suggests	 a	 role	 for	 RUNX	 in	 the	 innate	immunity	of	non-hematopoietic	cells.	This	review	takes	a	hematopoiesis-centric	approach	 to	 collate	 what	 is	 known	 of	 RUNX’s	 contribution	 to	 the	 overall	mammalian	immune	system	and	discuss	their	growing	prominence	in	areas	such	as	autoimmunity,	inflammatory	diseases	and	mucosa	immunity.		
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INTRODUCTION:	The	RUNX	family	of	transcription	factors	The	RUNX	proteins	are	evolutionarily	conserved	transcription	factors	that	share	the	 Runt-related	 domain	 for	 DNA	 binding	 and	 heterodimerization	 with	 a	common	 partner,	 CBFβ	 1.	 In	 diverse	 metazoans,	 RUNX	 proteins	 function	 as	critical	lineage	determinants	and	in	mammals	are	represented	by	RUNX1,	2	and	3	 (also	 known	 as	 AML1/3/2,	 PEBP2αB/A/C,	 CBFα1/2/3).	 Mammalian	 RUNX	genes	 share	 additional	 common	 features,	 which	 include	 the	 use	 of	 two	promoters,	termed	P1	(distal)	and	P2	(proximal),	through	which	different	RUNX	isoforms	are	derived	 1.	RUNX1	was	originally	 identified	as	 a	 frequent	 target	of	leukemogenic	 chromosomal	 translocations	 in	 human	 acute	 myelogenous	leukemia	 (AML)	 2.	 RUNX1	 is	 requisite	 for	 the	 generation	 and	 maintenance	 of	hematopoietic	stem	cells	(HSC)	and	the	differentiation	of	diverse	hematopoietic	lineages	 3.	 	 RUNX2	 is	 a	 master	 regulator	 of	 osteoblast	 differentiation	 and	necessary	 for	 bone	 and	 cartilage	 development	 and	 maintenance	 4.	Haploinsufficiency	in	RUNX2	due	largely	to	mutations	 in	 its	DNA-binding	Runt-domain	 results	 in	 human	 cleidocranial	 dysplasia	 (CCD)	 1.	 The	 expression	 of	RUNX3	is	necessary	for	the	differentiation	of	TrkC	positive	dorsal	root	ganglion	neurons	 and	 observed	 in	 a	 range	 of	 epithelial	 tissues	 1.	 Of	 relevance	 to	 this	review,	RUNX3	is	expressed	across	hematopoietic	lineages	where	its	distribution	overlaps	significantly	with	RUNX1	while	 remaining	distinct.	 In	comparison,	 the	expression	of	RUNX2	in	hematopoietic	lineages	is	less	studied,	except	in	specific	contexts,	while	CBFβ	isoforms	are	ubiquitously	expressed	across	many	tissues	at	approximately	 the	 same	 ratio	 5,	 6.	 Due	 to	 their	 profound	 involvement	 in	hematopoiesis	and	the	maturation	of	cell	lineages	involved	in	virtually	all	facets	of	 immunology,	 RUNX	 proteins	 hold	 important	 roles	 in	 host	 immunity.	 These	functions	 will	 be	 highlighted	 and	 discussed	 in	 the	 following	 sections	 that	describe	RUNX’s	contribution	to	each	major	hematopoietic	lineage.		
RUNX	and	hematopoietic	stem	cells	The	hematopoietic	stem	cells	(HSC)	are	the	multipotent	stem	cells	from	which	all	hematopoietic	 lineages	 are	 derived.	 Developmentally,	 the	 mammalian	hematopoietic	system	can	be	demarcated	into	three	discrete	phases:	1)	primitive	hematopoiesis	 during	 embryogenesis;	 2)	 definitive	 hematopoiesis	 in	 late	 fetal	development;	and	3)	adult	hematopoiesis.	The	 importance	of	RUNX	proteins	to	hematopoiesis	 was	 first	 revealed	 in	 the	 complete	 absence	 of	 definitive	hematopoiesis	in	Runx1	knockout	mice.	The	loss	of	Runx1	completely	abolished	the	transition	of	the	first	definitive	HSC	from	hemogenic	endothelial	cells	at	the	aorta-gonadal-mesonephros	(AGM)	region	7-12.	Runx1	was	also	necessary	for	the	maintenance	 of	 HSC	 in	 adult	 hematopoiesis,	 though	 not	 essential	 for	 their	biogenesis.	 Several	 studies	 showed	 that	 conditional	 targeting	of	Runx1	 in	bone	marrow	 (BM)	 HSC	 in	 adult	 mice	 by	 Mx1-Cre	 resulted	 in	 defective	 T	 and	 B	lymphocyte	 development	 at	 various	 stages	 and	 a	 blockade	 of	 megakaryocyte	maturation	13-15.	Unexpectedly,	some	studies	reported	an	initial	expansion	of	the	Runx1-deficient	 HSC	 that	 was	 followed	 by	 their	 progressive	 exhaustion	 13-17.	These	paradoxical	phenotypes	were	attributed	 in	part	 to	 the	premature	exit	of	HSC	from	its	cellular	niche	due	to	the	mis-regulation	of	the	chemokine	receptor	
Cxcr4	 17,	 18.	 These	 HSC	 defects	 were	 strongly	 accentuated	 when	 Runx3	 was	
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concurrently	 deleted,	 suggesting	 that	 Runx	 proteins	 served	 overlapping	functions	 in	 the	 homeostatic	 maintenance	 of	 HSC	 19.	 Indeed,	 Runx1;Runx3	deletion	 in	 the	 BM	 led	 to	 profound	 differentiation	 and	 proliferative	 disorders	across	 all	 hematopoietic	 lineages,	 eventually	 causing	 bone	 marrow	 failure	 or	myeloproliferative	 disorder	 (MPD)	 19.	 Similarly,	 pan-hematopoietic	 deletion	 of	
Cbfb	severely	impaired	differentiation	of	all	hematopoietic	lineages	and	resulted	in	proliferative	disorder	in	myeloid	cells	20,	21.	Interestingly,	Mx1-cre	targeting	of	
Cbfb	did	not	cause	 lethal	bone	marrow	failure	observed	in	Runx1;Runx3	double	KO	 mice,	 concordant	 with	 a	 Cbfβ-independent	 role	 for	 Runx1	 and	 3	 in	 DNA	repair	19.		
The	role	of	RUNX	in	thymocytes	differentiation	A	 major	 aspect	 of	 RUNX’s	 contribution	 to	 immune	 function	 is	 in	 the	differentiation	and	maturation	of	T	 cells,	which	has	been	 investigated	 in	detail	through	 mouse	 genetics	 (reviewed	 in	 Collins	 et	 al.	 22).	 In	 all	 stages	 of	 T	 cell	development,	RUNX	proteins	are	expressed	in	overlapping	but	distinct	patterns	and	differential	expression	levels	5	(Table	1).	The	expression	of	Runx	proteins	in	the	 thymus	 goes	 beyond	 the	 hematopoietic	 system	 and	 extends	 to	 the	 thymic	epithelial	cells	(TEC)	(Sela	A	&	Abramson	J,	personal	communication).	Runx1	is	most	 highly	 expressed	 in	 the	 thymic	 cortex	 where	 CD4-CD8-	 double	 negative	(DN)	 thymocytes	 reside,	 reaching	 an	 apex	 at	 the	 DN3	 stage	 before	 a	 sharp	decline	 5,	23-25.	Thereafter,	Runx1	expression	 is	maintained	 in	CD4+CD8+	double	positive	(DP)	and	CD4+	and	CD8+	single	positive	(SP)	cells,	with	the	expression	in	the	CD4+	SP	cells	being	higher	25-27.	In	line	with	this,	the	targeting	of	Runx1	in	BM	by	Mx1-Cre	and	thymocytes	by	lck-Cre	resulted	in	a	maturation	block	of	DN3	and	DN4	 thymocytes,	 respectively.	 Moreover,	 the	 ablation	 of	 Runx1	 using	 Cd4-cre	disrupted	DP	to	SP	 transition	13,	26.	 In	human	and	mouse,	 these	events	coincide	with	 the	 involvement	 of	 Runx1	 in	 T	 cell	 receptor	 (TCR)	 γδ	 and	 TCR	 αβ	rearrangement,	 respectively	 (Figure	 1)	 28-31.	 Runx1	 orchestrates	 TCR	rearrangement	 events	 by	 binding	 to	 the	 corresponding	 TCR	 chains	 enhancers	and,	 in	 human	 Dδ2	 to	 Dδ3	 rearrangement,	 resulting	 in	 the	 recruitment	 of	Recombination	 Activating	 Gene	 1	 (RAG1)	 through	 physical	 interaction	 32.	Collectively,	 these	studies	 firmly	establish	Runx1	as	a	key	driver	of	early	T	cell	development.	Compared	 with	 Runx1,	 Runx3	 gains	 prominence	 later	 in	 T	 cell	differentiation.	 It	plays	a	dominant	role	 in	 the	specification	of	CD8+	cytotoxic	T	(Tc)	cells	from	immature	CD4+CD8+	DP	cells.	This	is	achieved	through	a	number	of	mechanisms.	Firstly,	Runx3,	 and	also	Runx1,	bind	 to	 the	 silencer	 element	 in	the	Cd4	 locus	 to	suppress	 its	expression	 26,	33.	 Secondly,	 it	binds	 to	 the	silencer	element	 of	 Thpok,	 a	 key	 CD4	 lineage	 determinant	 33.	 Runx3	 also	 directs	 the	activity	of	other	participating	transcription	factors	that	regulate	Cd4	and	Thpok,	such	as	TCF-1	and	LEF-1	34.	Lastly,	the	binding	of	Runx	proteins	to	the	Cd4	and	
Cd8	 loci	 promotes	 their	 association	 and	 enables	 the	 long-range	 epigenetic	regulation	 that	 underlies	 their	 reciprocal	 expression	 patterns	 35.	 In	 line	 with	these	important	functions,	the	genetic	ablation	of	the	Runx	complex	resulted	in	the	blockade	of	CD8+	cytotoxic	T	lymphocytes	differentiation	and	a	redirection	of	their	development	to	a	CD4+CD8-	phenotype	26,	33.		
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RUNX	in	the	differentiation	of	effector	T	cell	subsets	Importantly,	Runx1	and	Runx3	are	 further	 involved	 in	 the	maturation	of	naïve	CD4+ T	 cells	 into	 various	 effector	 T	 lineages	 following	 TCR	 activation	 and	exposure	 to	environmental	cues.	 In	detail	 studies	of	 these	 lineages,	a	 recurring	theme	has	been	the	functional	cooperation	amongst	Runx	proteins	and	primary	lineage-specifying	 transcription	 factors	 36.	 During	 Th1	 differentiation,	 Runx3	expression	 increases	 with	 a	 corresponding	 reduction	 in	 Runx1	 expression.	Accordingly,	 Th1	 differentiation	 and	 cytokine	 production	 were	 found	 to	 be	impaired	in	Runx3-deficient	mice	37.	Reprising	 its	dualistic	role	 in	silencing	Cd4	while	activating	Cd8,	Runx3	cooperated	with	T-bet,	a	Th1-specific	transcription	factor,	 to	 fortify	 the	Th1	phenotype.	Together	with	Runx1,	Runx3	concurrently	activated	 the	 hallmark	 Th1	 cytokine	 Ifng	 while	 suppressing	 the	 Th2-specific	cytokine	Il4	37-39.	Though	not	studied	in	detail,	increase	in	Runx1	and	decrease	in	
Runx3	expression	were	observed	during	Th2	specification,	suggesting	a	role	for	Runx1	in	Th2	functions	37,	38.	Regulatory	T	(Treg)	cells	co-expressing	CD4	and	CD25	may	arise	spontaneously	in	the	thymus	(naturally	occurring	Treg	or	nTreg)	or	when	induced	by	TGF-β,	IL-2	 and	 other	 signaling	 cues	 in	 the	 periphery	 (induced	 Treg	 or	 iTreg)	 40,	41.	 The	Treg	phenotype	 is	 driven	by	 the	 transcription	 factor	 Foxp3.	Runx	proteins	 are	essential	 for	 the	 maintenance	 of	 Foxp3	 expression	 in	 nTreg	 and	 its	 induction	during	iTreg	differentiation	42-45.	Furthermore,	Runx	proteins	physically	interact	with	 Foxp3	 to	 maintain	 the	 Treg	 genetic	 programme,	 which	 includes	 the	repression	of	Il2	42,	45,	46.	Consequently,	the	conditional	ablation	of	Runx1,	Runx3	or	Cbfb	in	mice	strongly	disrupted	nTreg	and	iTreg	differentiation,	maintenance	and	 function	 42-44.	 In	 particular,	 Treg	 defects	 due	 to	 Runx/Cbfβ-deficiency	resulted	 in	 lymphoproliferative	 syndrome,	 hyper-production	 of	 IgE,	 and	autoimmunity	in	mucosal	tissues,	such	as	stomach	and	lung	42,	43.	Of	note,	these	phenotypes	are	reminiscent	to	the	severe	gastrointestinal	and	lung	inflammation	reported	 in	 a	 Runx3-deficient	 mouse	 model,	 which	 had	 been	 attributed	 to	spontaneous	maturation	of	dendritic	cells	(DC)	47,	48.		In	addition	to	the	 induction	of	 iTreg	cells,	TGF-β	 is	also	essential	 for	the	differentiation	 of	 Th17,	 a	 potent	 mediator	 of	 inflammation	 41,	 49,	 50.	 This	 is	dependent	 on	 concurrent	 stimulation	 by	 proinflammatory	 cytokines,	 including	IL-6,	TNFα	and	IL-1β	51.	While	Th17	cells	are	 important	 in	providing	 immunity	against	bacteria	and	fungus	at	mucosal	surfaces,	deregulation	and	hyperactivity	of	 Th17	 cells	 are	 linked	 strongly	 to	 the	 development	 of	 autoimmune	 diseases	(reviewed	in	Ivanov	et	al.	49	and	Singh	et	al.	52).	As	Runx	proteins	are	important	downstream	mediators	of	TGF-β,	their	involvement	in	the	reciprocal	induction	of	Treg	and	Th17	was	extensively	 investigated	41,	50.	Analogous	to	their	regulation	of	 Foxp3,	 Runx	 proteins	 acts	 upstream	 of	 Th17-specifying	 transcription	 factor	RORγt	 53-55.	 Furthermore,	Runx	proteins	physically	 interact	with	RORγt	 for	 the	maximal	 induction	 of	 Il17,	 in	 a	 manner	 independent	 of	 their	 DNA-binding	activities	 55.	 Remarkably,	 Foxp3	 also	 interacts	 with	 RORγt,	 which	 leads	 to	 the	suppression	of	 Il17	 transcription	 55.	A	picture	 therefore	emerges	of	 a	 tripartite	relationship	between	Runx,	Foxp3	and	RORγt	 in	Th17	lineage	specification	and	effector	 function,	 namely	 the	 secretion	 of	 IL-17	 55.	 It	 is	 now	 recognized	 that	Th17-associated	autoimmune	inflammation	 is	mediated	by	a	pathogenic	subset	of	Th17	characterized	by	high	IL-23	receptor	expression	and	the	production	of	
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IFN-γ,	normally	a	Th1	cytokine	56.	Recently,	it	was	shown	that	IFN-γ	production	by	 pathogenic	 IL23Rhigh	Th17	 cells	 required	 T-bet	 and	 Runx1/3,	 hence	 linking	Runx	 proteins	 in	 the	 pathogenesis	 of	 certain	 autoimmune	 conditions	 57.	Consistent	 with	 this,	 increased	 Runx1	 and	 decreased	 Runx2	 levels	 were	associated	with	salt-induced	pathogenic	Th17	58-60.	In	the	 intestinal	mucosa	where	strong	environmental	cues	such	as	TGFβ	and	retinoic	acid	(RA)	influence	T	cell	differentiation,	plasticity	in	the	CD4+	T	cell	lineage	 helps	 maintain	 homeostasis	 by	 preventing	 exaggerated	 responses	 to	commensal	 microbiota	 61-63.	 During	 their	 migration	 to	 the	 intestinal	intraepithelial	 compartment,	 progenitors	 of	 intestinal	 epithelial	 lymphocytes	(IELs)	 express	 Runx3	 in	 response	 to	 IL-15	 signaling	 to	 endow	 a	 CD4+	 CD8αα+	phenoytpe	 64-66.	 Moreover,	 Runx3	 confers	 CD4+	 IELs	 cytotoxic	 T	 lymphocyte	(CTL)	and	innate-like	lymphocyte	properties	and	attenuates	Th17	differentiation	in	 a	TGFβ-	 and	RA-dependent	manner	 65.	As	 in	 the	 case	of	Th1	differentiation,	Runx3	 is	 positively	 regulated	 by	 T-bet	 and	 partners	 it	 in	 executing	 the	 IEL	differentiation	program,	such	as	the	down-regulation	of	ThPOK	37,	66,	67.	While	 the	 necessity	 of	 Runx3	 for	 the	 specification	 and	 TCR-mediated	expansion	of	SP	CD8+	cytotoxic	T	cell	was	a	seminal	discovery,	the	role	of	Runx	proteins	 in	 the	 effector	 functions	 of	 mature	 CD8+	 T	 cell	 awaits	 further	investigation	 26,	33,	68.	Nevertheless,	 it	 is	 evident	 that	Runx	proteins	are	 integral	components	of	 lineage	specifying	 transcriptional	circuit.	 In	particular,	Runx3	 is	requisite	 for	 the	 induction	of	T-box	protein	Eomesodermin	(Eomes)	during	the	differentiation	 of	 cytotoxic	 T	 cells	 (Tc/CTL).	 Runx3-deficient	 CD8+	 Tc	 cells	showed	reduced	cytolytic	activity	due	to	weakened	TCR-induced	proliferation	26,	69	and	reduced	expression	of	key	Tc	effector	genes,	including	granzyme,	perforin	and	IFN-γ	39.		Runx	 is	 important	 also	 in	 the	 development	 of	 NKT	 cells,	 which	 are	specialized	T	lymphocytes	that	are	CD1d-restricted	and	co-express	TCRα/β	and	NK	maturation	markers,	like	NK1.1	(CD161)	70-72.	In	particular,	Runx1	(together	with	RORγT)	 is	 indispensable	 for	the	differentiation	of	 iNKT,	a	subclass	of	NKT	cells	 with	 an	 invariant	 TCR	 α	 chain	 71.	 These	 invariant	 NKT	 cells	 have	 been	implicated	 in	 diverse	 immunological	 processes,	 including	 immune	 regulation,	cytokine	 production,	 microbial	 immunity	 and	 autoimmunity	 70,	 73,	 74.	 However,	due	to	the	lack	of	NKT-specific	Cre	mouse	line,	the	precise	contribution	of	Runx	complex	in	NKT	cell	functions	remains	to	be	determined.		Lastly,	 Runx3	 is	 critical	 for	 the	 development	 of	 dendritic	 epidermal	 T	 cells	(DETC),	a	distinct	skin-associated	intraepithelial	γδ	T	cells	marked	by	a	dendritic	morphology	 75.	Runx3	 regulates	 IL-2Rβ	and	CD103,	which	mediate	 IL-2/IL-15-induced	cell	proliferation	and	the	migration	of	thymic	DETC	to	skin	during	 late	fetal	 development,	 respectively	 75,	 76.	 As	 DETC	 are	 a	 major	 component	 of	cutaneous	 immunity	 and	 homeostasis,	 the	 effects	 of	 their	 complete	 absence	 in	Runx3-deficient	mice	 on	 immune	modulation,	 surveillance	 and	 repair	warrant	further	investigation	75,	77.	
	
RUNX	in	B	cell	determination	and	functions	A	role	for	Runx	proteins	in	B	cell	function	was	first	revealed	in	a	series	of	in	vitro	and	 ex	 vivo	 experiments,	 in	 which	 Runx3	was	 shown	 to	 cooperate	 with	 Smad	
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proteins	 to	 mediate	 the	 induction	 of	 germline	 Ig	 α	 promoter	 by	 TGF-β	 78-82	(Figure	 2).	 This	 is	 a	 key	 event	 of	 IgA	 class	 switching	 when	 naïve	 B	 cells	 are	activated	 by	 antigen.	 In	 agreement	 with	 these	 observations,	 Runx3-	 and	Runx2;Runx3-deficient	splenocytes	displayed	varying	degrees	of	class	switching	defects	ex	vivo	and	in	vivo	82,	83.	In	addition	to	Runx3,	Runx1	is	requisite	for	early	B	lineage	specification	in	mouse.	The	targeting	of	Runx1	by	Mx1-Cre	in	adult	BM	resulted	in	a	blockade	of	B220+	B	cell	differentiation	from	common	lymphocyte	progenitors	 (CLP)	 13,	14.	 This	 early	 involvement	 stemmed	 in	 part	 from	Runx1’s	cooperation	 with	 the	 EBF	 transcription	 factor	 in	 its	 regulation	 of	mb-1	 (also	
Cd79a),	a	component	of	the	B	cell	receptor	84.	Consequently,	conditional	ablation	of	Runx1	and	Cbfb	(but	not	Runx3)	by	mb1-Cre	blocked	early	B	lymphopoiesis.	Of	note,	pre-proB	to	pro-B	transition	was	impaired,	resulting	in	a	loss	of	IgM+	B	cells	and	 reduced	 VH	 to	DJH	 recombination	 85.	 Although	 not	 fully	 elucidated,	 Runx1	appears	an	integral	component	of	early	B	lineage	specification	circuit	through	its	regulation	of	key	lineage	determinants,	such	as	the	pre-B	cell	receptor	84-86.		In	 contrast,	 Runx3	 gains	 prominence	 in	 later	 stages	 of	 B	 cell	differentiation.	An	example	of	this	was	the	strong	induction	of	Runx3	observed	in	mouse	B	cell	 lines	by	TGF-β	 in	naïve	B	cells	during	 IgA	class	switching	and	the	differentiation	of	effector	B	cells	78-81,	87.	Increased	RUNX3	expression	could	also	be	observed	 following	mitogenic	or	antigenic	stimulation	of	primary	B	cells,	as	well	 as	 during	Epstein-Barr	 virus	 (EBV)	 induced	 immortalization	 88.	 As	with	T	cell	 development,	 cross	 regulation	between	Runx	proteins	 and	 their	 reciprocal	expression	 during	 B	 cell	 differentiation	 has	 been	 reported	 89.	 This	 is	 most	pronounced	in	the	suppression	of	RUNX1	by	RUNX3	during	EBV	immortalization	of	resting	B	cells	to	generate	proliferating	B	lymphoblastoid	cells	88,	90,	91.	This	is	achieved	 by	 the	 silencing	 of	 RUNX1	 distal	 P1	 promoter	 through	 the	 VWRPY	domain	 within	 RUNX3	 92.	 Furthermore,	 RUNX3	 is	 recruited	 by	 EBNA2	 and	EBNA3C	 to	 co-occupy	 promoter	 and	 enhancer	 elements	 to	 modulate	 key	regulatory	 proteins,	 such	 as	 CDKN2A/p14ARF	 and	 B-cell	 maturation	 antigen	(BCMA)	91-93.	BCMA	plays	an	important	role	in	the	survival	of	B	cells,	particularly	in	mature	memory	B	cells	(Bmem)	and	plasma	B	cells	94.		In	 human,	 a	 distinct	 subpopulation	 of	 CD27-independent	 FCRL4+	 Bmem	cells	 resides	 in	 the	 palatine	 tonsils,	 crypt	 epithelium	 and	 intestine-associated	lymphoid	 tissues.	 The	 expression	 of	 RUNX1	 was	 found	 correlated	 to	 the	maintenance	of	 these	Bmem	cells	 in	an	undifferentiated	FCRL4-	state	 through	 its	physical	occupancy	FCRL4	promoter	95.	 	As	in	the	case	of	naïve	B	cell	activation	and	 EBV	 immortalization,	 the	 maturation	 and	 expansion	 of	 FCRL4+	 Bmem	cells	coincided	with	a	loss	of	RUNX1	expression	95.	Taken	together,	RUNX1	appears	to	be	necessary	for	the	maintenance	of	immature	and	undifferentiated	B	cells	while	RUNX3	 and	 RUNX2	 expression	 are	 observed	 during	 terminal	 specialization	 of	effector	B	cells	96.			
RUNX	in	lymphoid	organogenesis		Recently,	 the	 Runx/Cbfβ	 complex	 has	 been	 implicated	 in	 the	 development	 of	lymphoid	 tissue	 inducers	 (LTi)	 cells	 72.	 These	 are	 specialised	 innate	 lymphoid	cells	expressing	Rorγt	and	IL-7Rα	in	the	absence	of	additional	 lineage	markers.	
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They	 are	 essential	 for	 the	 biogenesis	 of	 secondary	 lymphoid	 tissues,	 such	 as	lymph	 nodes	 (LN)	 and	 Peyer’s	 patches	 by	 initiating	 anlagen	 formation	 97.	Runx1c,	a	Runx1	isoform	derived	from	the	P1	promoter,	and	Cbfβ2	are	involved	in	 LTi	 differentiation	 at	 two	 distinct	 development	 stages	 72.	 Specifically,	Runx1c/Cbfβ2	 are	 needed	 for	 the	 early	 specification	 of	 LTi	 differentiation	 and	during	 the	 formation	 of	 LN	 anlagen	 72.	 Consequently	 Runx1c/Cbfb2	 knockout	mice	 showed	 defective	 LTi	 differentiation	 and	 impaired	 lymphoid	 tissue	organogenesis,	particularly	Peyer’s	patches	and	periphery	LN	72.	Runx1c/Cbfβ2	are	likely	to	mediate	these	functions	through	their	regulation	of	Rorγt	72.	This	is	reminiscent	of	the	functional	interaction	between	Runx/Cbfβ	and	Rorγt	during	T	helper	 and	 iNKT	 differentiation,	 providing	 a	 clear	 example	 of	 recurrent	utilization	of	transcriptional	axes	during	hematopoiesis	55,	71,	72.	
	
RUNX	proteins	in	Natural	Killer	cells	development	Natural	Killer	 (NK)	 cells	 are	 a	 distinct	 subset	 of	 cytotoxic	 lymphocytes	 lineage	that	plays	important	roles	in	innate	immunity,	particularly	against	viral	infection	and	tumour	cells	 98.	They	are	unique	 in	 their	ability	 to	recognize	target	cells	 in	the	absence	of	antibodies	or	MHC	molecules,	relying	instead	on	a	separate	set	of	receptors	 for	 immune	 recognition	 and	 self	 tolerance	 99.	 NK	 cells	 develop	 in	multiple	 sites,	 including	 fetal	 and	 adult	 liver,	 BM,	 spleen	 and	 thymus.	 Their	differentiation	from	the	NK	progenitor,	marked	by	the	expression	of	CD122	(IL-2/IL-15	receptor	β	chain)	 is	 reliant	on	 IL-15	signalling	 98.	The	 first	evidence	of	Runx	 complex	 having	 a	 role	 in	 NK	 cells	 came	 in	 a	 hypomorphic	 Cbfβ	 mouse	model,	 in	which	an	early	block	in	NK	differentiation	was	observed.	At	 low	Cbfβ	dosage,	 the	 fetal	 liver	 cells	 displayed	 a	 profound	 defect	 in	 their	 ability	 to	generate	 NK1.1-CD122+	 NK	 progenitor	 cells	 in	 ex	 vivo	 culture	 100,	101.	 This	was	likely	 due	 to	 a	 loss	 of	 Runx	 complex-mediated	 CD122	 transcription,	 thereby	blocking	 the	 crucial	 IL-15-induced	 genetic	 programme	 102.	 Runx	proteins	were	shown	 to	 occupy	 and	 regulate	 the	 CD122	 promoter	 in	mouse	 NK	 progenitors,	while	a	dominant	negative	Runx	mutant	suppressed	CD122,	Ly49	family,	Mac-1	and	 CD43	 expression	 102,	 103.	 Due	 to	 its	 dominant	 expression,	 these	 studies	implicated	 an	 important	 role	 for	 Runx3	 during	 NK	 cell	 development	 101,	 102.	Direct	 evidence	 was	 provided	 in	 a	 recent	 study	 of	 Runx3-deficient	 mice.	Although	 Runx3	 was	 found	 largely	 dispensable	 for	 NK	 cell	 development	 and	function	 in	 resting	 conditions,	 it	 was	 requisite	 for	 IL-15-induced	 NK	 cell	proliferation	 and	 maturation	 in	 vivo	 and	 ex	 vivo	 104.	 In	 particular,	 the	 loss	 of	Runx3	 resulted	 in	 the	 complete	 loss	 of	 IL-15-dependent	 uterine	 NK	 cells	 in	pregnant	mice	 104.	 	However,	due	 to	 the	 limitation	 in	 current	mouse	models,	 it	remains	 unresolved	 whether	 Runx	 proteins	 are	 further	 necessary	 for	 NK	functions,	such	as	IFN-γ	production	and	tumor	immunity	101,	102,	104.		
RUNX	in	myeloid	cell	specification	and	functions	Relatively	 little	 is	 known	 of	 the	 contribution	 of	 RUNX	 to	 myeloid	 cell	development	 and	 functions.	 Initial	 mouse	 studies	 showed	 that	 the	 deletion	 of	Runx1	in	adult	HSC	severely	impaired	megakaryocyte	maturation	but	displayed	no	discernable	defect	 in	 the	differentiation	of	other	myeloid	 lineages,	 including	neutrophils,	 monocytes	 and	 erythrocytes	 13-15.	 This	 comparatively	 mild	phenotype	is	likely	due	to	a	greater	degree	of	redundancy	shared	between	Runx	
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proteins	 in	 myeloid	 differentiation	 19-21.	 Indeed,	 clearer	 phenotypes	 were	observed	 upon	 the	 pan-hematopoietic	 targeting	 of	 Cbfb	 by	 Vav1-iCre,	 which	disrupted	 the	 function	 of	 all	 Runx	 proteins.	 This	 led	 to	 severe	 reductions	 of	classical	 and	 plasmacytoid	 dendritic	 cells	 (DC)	 in	 the	 spleen	 and	 peripheral	tissues,	 including	 the	 lung	 and	 intestinal	 lamina	 propria.	 Cbfβ	 was	 found	requisite	 for	 the	 development	 of	 Flt3+	 DC	 progenitors,	 as	 well	 as	 erythroid	progenitors	in	the	BM	20.	Further	analysis	revealed	that	Runx1	was	the	primary	driver	of	the	Cbfβ	knockout	DC	phenotype,	with	Runx2	playing	a	minor	role	later	in	 DC	 maturation.	 However,	 no	 role	 was	 ascribed	 to	 Runx3,	 in	 contrast	 with	earlier	 reports	 of	 aberrant	 DC	 development	 and	 spontaneous	maturation	 in	 a	
Runx3	 knockout	 mouse	 20,	 48,	 83.	 Notwithstanding	 this	 discrepancy,	 Runx3	 is	needed	 Langerhans	 cells	 (LC),	 which	 are	 a	 distinct	 skin	 epidermal	 DC	 lineage	derived	 from	 myeloid	 progenitors	 early	 in	 embryogenesis	 83,	 105.	 Here,	 Runx3	acts	 downstream	 of	 PU.1	 to	 promote	 LC	 differentiation	 induced	 by	 TGFβ	signaling	105.		In	addition	to	DC	differentiation	and	maturation,	RUNX3	regulates	CD11c	and	chemokine	expression	 in	an	 isoform-specific	manner	 in	vitro	 106.	As	DC	are	central	 coordinators	 of	 adaptive	 immune	 responses	 and	 self-tolerance,	 the	importance	of	Runx	proteins	in	their	differentiation	will	have	far-reaching	effects	in	 the	 immune	 system.	 	 In	 addition	 to	DC,	 a	 recent	 study	 showed	 that	 specific	ablation	 of	 the	 Runx1c	 isoform	 in	 mice	 resulted	 in	 a	 drastic	 reduction	 in	granulocytic	 basophils,	 owing	 to	 a	 block	 in	 the	 transition	 of	 granulocyte	progenitors	to	basophil	progenitors.	Furthermore,	Runx1c-deficiency	specifically	attenuated	 basophil	 (and	 not	 mast	 cells)	 functions,	 including	 IgE-mediated	chronic	 allergic	 skin	 reaction,	 and	 their	 expansion	 in	 response	 to	 IL-3	 or	nematodes	107.	In	monocytes	and	macrophages,	RUNX1	cooperates	with	PU.1	to	regulate	macrophage	 colony-stimulating	 factor	 (M-CSF/CSF-1)	 receptor,	 which	 is	essential	 for	 the	 survival,	 differentiation	and	expansion	of	macrophages	 108,	109.	RUNX1	 and	 RUNX3	 are	 also	 important	 controllers	 of	 adhesive	 interactions	through	their	regulation	of	integrin-like	LFA-1/CD11a,	CD11c,	CD49d	and	ICAM-3	 in	 macrophage	 and	 monocytic	 cell	 lines	 110-112.	 Of	 note,	 LFA-1	 and	 ICAM-3	interaction	 contribute	 to	 the	 polarization	 of	 Th1	 cells,	 highlighting	 the	multifaceted	contribution	of	RUNX	to	T	cell	differentiation	and	function	111.	The	microglia	are	unique	phagocytic	cells	 that	reside	within	 the	parenchyma	of	 the	central	 nervous	 system	 (CNS),	 where	 they	 serve	 as	 inflammatory	 cells	 that	safeguard	the	CNS	against	microbes	and	injuries.	Akin	to	the	LCs,	microglia	are	derived	 from	Runx1+	yolk	 sac	primitive	myeloid	progenitors	 and	are	 seeded	 in	the	 CNS	 during	 embryonic	 and	 perinatal	 stages	 of	 development	 113-115.	Postnatally,	Runx1	was	 reported	 to	 inhibit	 proliferation	of	 immature	microglia	and	 promote	 their	 maturation	 115.	 Interestingly,	 Runx1	 expression	 was	reactivated	 following	 injury	 to	 the	 nervous	 system,	 suggesting	 a	 role	 in	 the	function	of	mature	microglia	in	CNS	surveillance	and	repair	115.			
RUNX	in	inflammation	and	autoimmunity	
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In	 the	 thymus,	 the	 induction	 of	 self-tolerance	 by	 nTreg	 is	 essential	 for	 the	maintenance	 of	 immune	 homeostasis,	 the	 loss	 of	 which	 would	 lead	 to	autoimmunity	 116.	 Given	 the	 heavy	 involvement	 of	 RUNX	 proteins	 in	differentiation	and	function	of	nTreg	and	iTreg	42-46,	as	well	as	that	of	Th17	cells	53,	 55,	 it	 is	 likely	 that	 the	 interference	 of	 RUNX	 function	 would	 contribute	 to	autoimmune	 and	 inflammatory	 disease	 states.	 This	 possibility	 is	 supported	 by	several	 extensive	 studies	 of	 genetic	 association	 in	 human	 autoimmune	conditions.	 Firstly,	 an	 intronic	 SNP	within	 the	PDCD1	 locus	 that	 alters	 a	RUNX	binding	 site	 was	 associated	 with	 systemic	 lupus	 erythematosus	 (SLE)	 in	 an	ethnically	diverse	cohort.	The	alteration	in	RUNX	site	disrupted	RUNX1	binding	
in	 vitro	 and	 led	 to	 aberrant	 expression	 of	 PDCD1,	 which	 is	 important	 to	 self-tolerance	and	the	suppression	of	hyperactivity	 in	SLE	 117.	Of	note,	PDCD1	(also	called	PD-1)	is	a	negative	regulator	of	tumor	immunity	and	an	important	target	of	 cancer	 immunotherapy	 118.	 	 Similarly,	 a	 RUNX	 site	 variant	 between	 a	 PDZ-domain	phosphoprotein	SLC9A3R1	and	N-acetyltransferase	NAT9	was	associated	with	psoriasis,	a	chronic	inflammatory	skin	disorder	119.	In	addition,	the	RUNX1	locus	and	a	RUNX	site-ablating	SNP	in	the	transporter	gene	SLC22A4	were	found	to	be	significantly	associated	with	rheumatoid	arthritis	120.	It	bears	highlighting	that	the	disease-associated	RUNX	sites	could	function	as	the	binding	targets	of	all	RUNX	 proteins	 as	 they	 recognize	 the	 same	 cognate	 sites	 117,	119,	120.	 Consistent	with	 this,	 a	 Runx3	 knockout	 mouse	 model	 spontaneously	 developed	 an	inflammatory	bowel	disease	(IBD)-like	condition	characterized	by	infiltration	of	leukocytes	with	mixed	Th1/Th2	response	and	hyperplastic	mucosa	47.	In	human,	the	chromosomal	region	1p36	where	RUNX3	resides	is	a	susceptibility	region	for	IBD	 121-123.	 More	 recently,	 genome-wide	 association	 studies	 (GWAS)	 identified	variants	 in	the	RUNX3	 locus	to	be	associated	with	two	subtypes	of	 IBD,	namely	celiac	disease	and	ulcerative	colitis	 124,	125.	Lastly,	SNPs	within	 the	RUNX1	 locus	and	 RUNX1	 levels	 were	 also	 found	 associated	 with	 pediatric	 asthma	 126.	Together,	the	above	findings	suggest	that	alteration	of	RUNX	functions	could	lead	to	 dysregulated	 self-tolerance,	 chronic	 lymphocyte	 hyperactivity	 and	autoimmunity	in	organs.			
Established	and	emerging	roles	of	RUNX	in	mucosal	immunity		 Although	direct	evidence	is	only	beginning	to	emerge,	RUNX	proteins	are	strongly	implicated	in	innate	and	adaptive	immunity	in	mucosal	systems.	RUNX	family	 members	 play	 important	 roles	 in	 the	 development,	 maturation	 and	effector	 functions	 of	 every	 major	 immune	 lineage	 within	 the	 mucosal	 system	(illustrated	 in	 Figure	 3).	 Importantly,	 RUNX	 is	 functionally	 integrated	 into	 the	overall	 immune	 response	 at	 multiple	 levels.	 An	 instance	 of	 this	 is	 in	 the	biogenesis,	organization	and	 function	of	mucosal	 lymphoid	 tissues,	 like	Peyer’s	patches	 72.	 In	addition	 to	 their	 formation,	Runx	proteins	also	participate	 in	 the	activation	of	periphery	T	and	B	 cells	within	 them	by	 regulating	DC	maturation	for	antigen	presentation	20,48,	83.	Following	activation,	the	terminal	differentiation	of	naïve	peripheral	T	cells	 is	coordinated	by	Runx	proteins	 in	partnership	with	various	 lineage-defining	 transcription	 factors,	 into	 effector	 T	 helper	 and	cytotoxic	lineages	22,	127.	Of	particular	relevance	in	the	mucosal	system	is	the	role	of	Runx1/3	in	the	differentiation	of	IELs	in	response	to	environmental	cues	and	pathogenic	 challenges	 65-67.	 Runx1	 is	 further	 involved	 in	 the	 development	 of	
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iNKT	 lymphocytes,	 which	 orchestrate	 microbial	 immunity	 through	 cytokine	production	 71,	 72.	 Concurrently,	 Runx3	 and	 Runx2	 are	 essential	 for	 IgA	 class	switching	 in	 mature	 B	 cells,	 a	 crucial	 event	 in	 the	 configuration	 of	 mucosal	immunity	in	response	to	microbial	pathogens	128.	Lastly,	RUNX1	is	implicated	in	the	 maturation	 of	 FCRL4+	 memory	 B	 cells	 that	 resides	 in	 gastrointestinal	epithelial	niche	95.		 Though	 less	 understood,	 Runx	 proteins	 function	 through	 innate	leukocytes	and	 lymphocytes	 to	mount	 innate	 immunity	at	 the	mucosa.	Of	note,	Runx3	 is	 necessary	 for	 the	 expansion	 and	maturation	 of	NK	 cells,	which	 serve	important	cytotoxic	functions	independent	of	antigen	presentation	104.	Similarly,	Runx1	is	needed	for	the	expansion	of	basophils	and	maximal	anti-parasitic	and	proinflammatory	 activities	 107.	 In	 macrophages	 and	 monocytes,	 RUNX	transcriptionally	 regulates	 adhesion	 complexes	 to	 promote	 their	 migration	 to	the	sites	of	infection	to	perform	their	phagocytic	functions	111,	112.		In	 addition	 to	 hematopoietic	 cells,	 a	 major	 component	 of	 mucosal	immunity	 is	 the	 epithelial	 cells	 that	 constitute	 the	 foremost	 barrier	 to	 the	mucosal	 microbiota.	 The	 precise	 contribution	 of	 this	 cell	 type	 to	 mucosal	immunity	 through	 antigen	 processing	 and	 cytokine	 production	 is	 currently	under-explored.	Likewise,	while	RUNX	proteins	are	important	in	a	diverse	range	of	 epithelial	 tissues,	 the	 potential	 for	 their	 immune	 contribution	 has	 not	 been	experimentally	 tested	 1.	 Recently,	 RUNX3	 was	 reported	 to	 transcriptionally	regulate	 IL23A	 in	 gastric	 epithelial	 cells	 129.	 IL23A	 is	 a	 subunit	 of	 IL-23,	 a	proinflammatory	 cytokine	 best	 known	 for	 driving	 Th17	 activities	 130.	Furthermore,	RUNX3	strongly	augmented	the	secretion	of	IL23A	in	the	presence	of	 the	 proinflammatory	 cytokines	 TNF-α	 and	 IL-1,	 and	 the	 gastric	 pathogen	
Helicobacter	 pylori	 129.	 These	 findings	 are	 conceptually	 significant	 as	 they	provide	evidence	that	RUNX	proteins	can	further	participate	in	innate	immunity	through	epithelial	cytokine	production.			
Concluding	remarks	It	 is	 evident	 that	 RUNX	 proteins	 are	 profoundly	 involved	 in	 the	development,	 organization	 and	 function	 of	 the	 mammalian	 immune	 system.	Much	 of	 these	 are	 accomplished	 through	 their	 multifaceted	 contribution	 to	definitive	 and	 adult	 hematopoiesis.	 In	 addition,	 RUNX	 is	 often	 recurrently	involved	 in	cell	 fate	decision	within	a	 lineage	 in	response	 to	extracellular	cues,	through	interplays	with	other	primary	lineage-determining	factors.	This	is	most	apparent	during	T	cell	differentiation,	where	an	antagonistic	 interplay	between	Runx	complex	and	Th-POK	determines	the	fate	of	CD8+	and	CD4+	SP	T	cells.	This	is	 revisited	 in	 activated	periphery	T	 cells,	where	RUNXs	 concurrently	 promote	one	T	helper	phenotype	while	suppressing	another	through	molecular	interplays	with	 T-bet,	 FoxP3	 or	 RORγT.	 Such	 observations	 are	 consistent	with	 the	 RUNX	loci	being	a	part	of	a	finely	tuned	high-order	transcriptional	circuit.	Importantly,	this	 circuit	 is	 functionally	 oriented	 and	 extends	 beyond	 hematopoietic	 lineage	decision.	For	example,	the	RORγT-RUNX	axis	impacts	diverse	immune	functions,	notably	 inflammation	 (via	 Th17	 cells),	 commensal	 microbe	 tolerance	 (iNKT	cells)	 and	 lymph	 node	 biogenesis	 (LTi	 cells).	 These	 observations	 indicate	 that	
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RUNX	proteins	are	amongst	the	primary	building	blocks	of	 the	 immune	system	during	evolution	131.	Therefore,	elucidating	the	spatial,	 temporal	and	functional	contribution	of	RUNX	to	the	dynamics	and	complexity	of	the	immune	system	is	an	 attractive	 goal.	 However,	 that	 RUNX	 functions	 are	 deeply	 woven	 into	 the	immune	 processes	 presents	 a	 significant	 technical	 challenge.	 Indeed,	 direct	evidence	of	their	contribution	to	overall	immunity	is	lacking	and	awaits	studies	combining	 lineage-specific	 gene	 targeting	 with	 immunologic	 challenges.	 It	 is	hoped	 that	 this	 immune	 oriented	 survey	 of	 current	 knowledge	 will	 stimulate	future	studies	of	RUNX	functions	beyond	hematopoiesis	into	immunity.				
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FIGURE	LEGENDS		
Figure	 1:	 RUNX	 and	 T	 lymphocytes	 differentiation.	 In	 the	 thymic	 cortex,	Runx1	 is	 expressed	 in	 CD4-CD8-	 double	 negative	 (DN)	 thymocytes,	 reaching	 a	maximum	 at	 DN3	 before	 declining	 during	 DN3	 to	 DN4	 transition.	 Runx1	transcriptionally	orchestrates	IL-7Rα-mediated	expansion,	T	cell	receptor	(TCR)	γδ	 and	TCR	αβ	 rearrangement	during	 these	developmental	 stages.	 In	 addition,	Runx1	is	also	a	key	factor	for	the	differentiation	of	invariant	NKT	(iNKT)	cells	in	the	 medulla	 cortex	 of	 the	 thymus.	 Following	 TCR-mediated	 selection,	 Runx3	gains	prominence	and	is	a	major	driver	of	CD8+	T	cell	differentiation	through	the	silencing	 of	 Cd4	 and	 Thpok,	 master	 regulator	 of	 CD4+	 differentiation.	 In	 the	periphery,	 Runx3	 promotes	 the	 maturation	 of	 CD8+	 T	 cells	 into	 cytotoxic	 T	lymphocytes	 (CTL)	 via	 its	 regulation	of	Eomes	 and	key	 effector	 genes.	 In	TCR-activated	CD4+	T	cells,	Runx3	cooperates	with	T-bet	to	fortify	the	Th1	phenotype	by	activating	Ifng	expression	while	suppressing	Th2-specific	cytokine	IL4.	Runx	proteins	 are	 also	 important	 in	 the	 differentiation	 and	 functions	 of	 Treg	 cells	through	 its	 regulation	 and	 interaction	 with	 Foxp3.	 Lastly,	 Runx	 proteins	influence	 the	 development	 of	 Th17	 in	 distinct	 ways.	 Runx	 could	 suppress	 or	activate	Rorγt	depending	on	the	presence	of	Foxp3,	while	interact	with	Rorγt	to	activate	 Il17	expression.	Moreover,	 Runx1/3	 are	 needed	 for	 the	 production	 of	IFN-γ	 in	 a	 subset	 of	 Th17	 cells	 important	 in	 the	 pathogenesis	 of	autoinflammatory	 conditions.	 In	 this	 figure,	 key	 T	 lineage	 determinants	 that	functionally	 interact	with	RUNX	 are	 labeled	 in	 blue	 and	notable	 effector	 genes	are	labeled	brown.	ETP	denotes	early	thymocyte	progenitors.		
Figure	2:	RUNX	in	B	cells	development	and	humoral	immunity.	In	adult	bone	marrow,	 Runx1	 is	 involved	 in	 the	 differentiation	 of	 B	 cell	 from	 common	lymphoid	progenitors	 (CLP).	 Specifically,	 Runx1	 regulates	 and	 cooperates	with	Ebf	for	the	transition	of	pre-proB	cells	to	pro-B	cells.	Runx1	also	takes	part	in	the	transition	of	large	pre-B	cells	to	small	pre-B	cells	via	VH	to	DJH	recombination	as	well	 as	 regulation	of	pre-B	cell	 receptor	 (BCR).	Runx3	 is	necessary	 in	 the	 later	stage	 of	 B	 cell	 development	 in	 secondary	 lymphoid	 tissues.	 Runx3	 and	 Runx2	function	downstream	of	TGFβ-mediated	 IgA	class	 switching,	 a	key	event	 in	 the	development	 of	 B	 lymphoblast.	 Runx1	 is	 also	 needed	 to	 maintain	 high	 IgA	expression	on	the	surfaces	of	activated	lymphoblasts.	In	human,	RUNX1	further	influences	the	differentiation	of	FCRL4+	memory	B	cells	that	normally	reside	in	mucosal	tissues.			
Figure	 3:	 The	 multifaceted	 contribution	 of	 RUNX	 in	 mucosal	 immunity.	(1)RUNX	proteins	 are	 essential	 for	 the	differentiation	and	effector	 functions	of	diverse	 cell	 lineages	 that	 participate	 in	 the	 mucosal	 immune	 system.	 These	include	T	cells,	B	cells	and	dendritic	cells	(DC)	for	adaptive	immunity;	as	well	as	macrophages,	NK	 cells	 and	 epithelial	 cells	 for	 innate	 immunity.	 (2)	Runx1	 and	Runx3	 are	 critically	 involved	 in	 the	 specification	 of	 CD8+	 cytotoxic	 T	 (Tc)	 and	naïve	CD4+	helper	T	(Th)	lymphocytes	prior	to	their	entrance	into	the	periphery.	Following	 antigen	 engagement	 and	 TCR	 activation,	 Runx1/3	 coordinate	 the	terminal	differentiation	of	CD4+	T	cells	into	Th1,	Th2,	Th17	and	Treg,	and	CD8+	T	cells	into	CTLs	effector	T	lineages.	(3)	In	B	lymphocytes,	Runx	play	a	crucial	role	
	 23	
in	 TGFβ-mediated	 IgA	 class	 switching	 following	 antigen	 engagement.	 Runx	proteins	 are	 also	 necessary	 for	 the	 maximal	 surface	 expression	 of	 IgA	 on	activated	B	lymphoblast	and	the	maintenance	of	specialized	memory	B	(Bmem)	cells	 distributed	 at	 the	 mucosa.	 (4)	 The	 Runx	 complex	 is	 required	 for	 the	formation	 of	 anlagen	 that	 initiate	 Peyer’s	 patches	 and	 periphery	 lymph	 node	biogenesis.	 These	 secondary	 lymphoid	 tissues	 are	 home	 to	 naïve	 periphery	lymphocytes	and	dendritic	cells	and	are	necessary	 for	maintaining	surveillance	and	homeostasis.	(5)	The	mucosal	epithelium	is	in	direct	contact	of	the	microbial	load	and	 functions	as	a	physical	as	well	as	 immune	barrier.	RUNX	proteins	are	functionally	 important	 in	 a	 diverse	 range	 of	mucosal	 epithelial	 cells,	 including	those	in	lung	and	gastrointestinal	tract.	Runx3	is	requisite	for	the	homeostasis	of	an	 intact	 mucosal	 epithelium	 by	 regulating	 the	 proliferation	 and	 apoptosis	 of	epithelial	 cells	 1.	 RUNX	 proteins	 may	 further	 contribute	 to	 innate	 immunity	within	the	epithelium	by	regulating	cytokine	production	(such	as	IL23A)	during	infection	and	inflammation	129.					
Lineage Differentiation step RUNX/CBFβ Description Immune functions affected when RUNX/CBFβ is disrupted References 
Thymocytes		 Runx1	 DN2	to	DN3	transition	by	regulating	IL7Rα,	TCRγδ	rearrangement	 Defective	TCR	rearrangement	and	thymocytes	maturation	 13-15,	26,	28,	29,	34	
CD4/CD8	 Runx3,1	 DP	to	CD8+	SP	differentiation,	TCRαβ	rearrangement	 Reduced	CD8+	Tc/CTL	numbers	 26,	30,	31,	33,	132		
	 Runx1	 DP	to	CD4+	TCR-αβ	rearrangement	 Reduced	Il7r	and	survival	 132	












	 Runx1,	3	 Promotes	pathogenic	Th17	and	secretion	of	IFN-γ	with	T-bet	 IL-17	and	IFN-γ	 57	 
IEL	 Runx3	 Necessary	for	CD8αα+	expression.	Cooperates	with	T-bet	to	suppress	Th-POK	 Accentuated	Th17	differentiation	 64-67	
Tc/CTL	 Runx3	 Necessary	for	CD8+	Tc	differentiation	 Reduced	CTL	activity	 26,	69,	132		 	 Regulates	Eomes,	granzyme,	perforin	and	IFN-γ	expression	 Reduced	CTL	activity	 39	
NKT	 Runx1,	Cbfβ	 Needed	for	iNKT	differentiation	 Undetermined	
71,	72	
T	lymphocytes	
Dermal	dendritic	T	cells	 Runx3	 Promotes	maturation	of	γ3	thymocyte	via	CD103	and	IL-2Rβ		 Loss	of	adult	skin	DETC	 75	















	 B	cell	maturation	 Runx3	 Cooperates	with	TGF-β	for	activating	germline	Ig	α	promoter Defective	IgA	class	switching	 78-82	
	 	 Runx1	 Promotes	surface	IgA	expression	in	activated	primary	B	cells	 Defective	IgA	class	switching	 82	
	 	 Runx3,	Runx2	 Necessary	for	IgA	expression	in	peripheral	B	cells	 Reduced	IgA	production	 82	
	 Memory	B	cells	 RUNX1	 Maintains	undifferentiated	state	by	silencing	FCRL4	 Undetermined	
95	
	 Primary	B	cells	 RUNX1	 Suppresses	proliferation	of	resting	B	cells	 Undetermined	
88	
	 	 RUNX3	 Immortalizes	B	cells	via	silencing	of	RUNX1	 Undetermined	 88,	89,	91,	92 
	 	 	 	 	 	
NK	cells	 NK	differentiation	 Cbfβ	 Needed	for	NK1.1-CD122+	progenitor	 Undetermined	 100,	101	
	 	 Runx3	 Regulates	CD122,	Ly49	family,	Mac-1	,CD43	and	IFN-γ	
Needed	for	IL-15-induced	NK	cell	proliferation	and	maturation	
Undetermined	 102,	103		104 
	 Uterine	NK	cells	 Runx3	 Essential	for	IL-15-dependent	uterine	NK	cells	 Loss	of	uterine	NK	cells	 104	 






	 	 Runx1	 Necessary	in	BM	cells	for	LTi	differentiation	 Absent	or	defective	Peyer’s	patches	 15		













	 	 	 	 	 	
	 Langerhans	cells	(LC)	 Runx3	 Mediates	TGF-β-induced	LC	differentiation		 Loss	of	Langerhans	cells	
83,	105	
	 	 	 	 	 	
	 Basophils	 Runx1c	 Required	for	generation	of	basophil	progenitors	 Attenuated	basophil	expansion	and	functions.	
107	
	 	 	 	 	 	
	 Monocytes/macrophage	 RUNX1	 Cooperates	with	PU.1	to	induce	M-CSFR	 Reduced	macrophage	survival,	differentiation	and	expansion	
108,	109	
	 	 RUNX3,1	 Regulates	LFA-	1/CD11a,	CD11c,	CD49d	and	ICAM-3	 Undetermined	
110-112	
	 	 	 	 	 	
	 Microglia	 Runx1	 Runx1	promotes	microglia	maturation	
Runx1	is	induced	during	nerve	injury	
Runx1	restricts	iNOS	production	in	vitro	 115	
	 	 	 	 	  
	 Gastric	epithelial	cells	 Runx3,Runx1	 Response	to	inflammation	and	infection	 Secretion	of	IL23A	 129	
	 	 	 	 	 	
 
Table 1: Role of RUNX proteins in the differentiation and effector functions of hematopoietic lineages. 	



